First drug to slow progression of Alzheimer's disease approved in US
Published
The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzheimer's disease for the first time.
Full ArticlePublished
The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzheimer's disease for the first time.
Full ArticleIn some really big news that is likely to get almost no media attention, Senator Bernie Sanders, the chair of the Senate HELP..
ViewAnother drug is showing promise for those at risk of Alzheimer's disease.
Donanemab, produced by Eli Lilly, could be..